{"date":"2025-05-16","count":15,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7773-2025-05-16-1828-1bcv4sg","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-16","time":"18:28:36","subject":"公告本公司取得會計師內部控制制度專案審查確信報告","clause":"第25款","fact_date":"2025-05-16","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2025-05-16 18:28，「公告本公司取得會計師內部控制制度專案審查確信報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-05-16-1803-bsfxdj","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-16","time":"18:03:28","subject":"公告本公司會計主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-05-16 18:03，「公告本公司會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-05-16-1740-vjfkzy","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-05-16","time":"17:40:59","subject":"公告本公司一針劑型及三針劑型透明質酸”FLEXVISC Plus”、”JETKNEE”、”FLEXVISC”關節腔注射劑產品取得銷售許可證書","clause":"第51款","fact_date":"2025-05-16","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-05-16 17:40，「公告本公司一針劑型及三針劑型透明質酸”FLEXVISC Plus”、”JETKNEE”、”FLEXVISC”關節腔注射劑」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-05-16-1730-1a8b3ve","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-16","time":"17:30:21","subject":"公告本公司董事會決議113年度第一次員工認股權憑證發行事宜(更正本公司原114年5月13日重大訊息-「公告本公司董事會決議通過113年員工認股權憑證發行日及發行認股價格」)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-05-16 17:30，「公告本公司董事會決議113年度第一次員工認股權憑證發行事宜(更正本公司原114年5月13日重大訊息-「公告本公司董事會決」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2025-05-16-1722-1ot2cvp","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2025-05-16","time":"17:22:13","subject":"本公司受邀參加花旗證券舉辦之投資論壇","clause":"第12款","fact_date":"2025-05-21","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2025-05-16 17:22，「本公司受邀參加花旗證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-05-16-1648-1aedtb1","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-05-16","time":"16:48:59","subject":"公告本公司董事會決議以自地委建方式興建竹南廠房事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-05-16 16:48，「公告本公司董事會決議以自地委建方式興建竹南廠房事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-05-16-1644-1uhskx3","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-05-16","time":"16:44:31","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-05-16 16:44，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-05-16-1638-tw6iuh","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-05-16","time":"16:38:31","subject":"公告本公司「速必一」新藥(研發代號:ON101)通過促進傷口癒合的外用製劑配方阿拉伯聯合大公國發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-05-16 16:38，「公告本公司「速必一」新藥(研發代號:ON101)通過促進傷口癒合的外用製劑配方阿拉伯聯合大公國發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-05-16-1603-1cm8031","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-05-16","time":"16:03:37","subject":"代重要子公司高峰藥品材料股份有限公司公告股東會決議通過解除董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-05-16 16:03，「代重要子公司高峰藥品材料股份有限公司公告股東會決議通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-05-16-1602-1x94z16","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-05-16","time":"16:02:58","subject":"代重要子公司高峰藥品材料股份有限公司公告除(權)息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-05-16 16:02，「代重要子公司高峰藥品材料股份有限公司公告除(權)息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-05-16-1602-atebb9","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-05-16","time":"16:02:26","subject":"代重要子公司高峰藥品材料股份有限公司公告114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-05-16 16:02，「代重要子公司高峰藥品材料股份有限公司公告114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-05-16-1506-i0lc2","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-05-16","time":"15:06:41","subject":"公告本公司訂定除權基準日等相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-05-16 15:06，「公告本公司訂定除權基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2025-05-16-1437-1x9o0kn","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2025-05-16","time":"14:37:43","subject":"本公司受邀參加匯豐證券之2025台灣論壇","clause":"第12款","fact_date":"2025-05-19","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2025-05-16 14:37，「本公司受邀參加匯豐證券之2025台灣論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-05-16-0609-15t8o52","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-05-16","time":"06:09:24","subject":"公告本公司開發中新藥L608獲歐盟藥品管理局孤兒藥委員會孤兒藥資格正面意見","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-05-16 06:09，「公告本公司開發中新藥L608獲歐盟藥品管理局孤兒藥委員會孤兒藥資格正面意見」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-05-16-0030-1pnx32j","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-05-16","time":"00:30:08","subject":"本公司向哈薩克醫療衛生主管機關遞交研發中產品EG1206A(pertuzumab生物相似藥)第三期臨床試驗計畫書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-05-16 00:30，「本公司向哈薩克醫療衛生主管機關遞交研發中產品EG1206A(pertuzumab生物相似藥)第三期臨床試驗計畫書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}